Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 22 | 2024 | 8037 | 1.520 |
Why?
|
Dementia | 4 | 2023 | 2518 | 0.810 |
Why?
|
Microglia | 7 | 2024 | 1266 | 0.800 |
Why?
|
Memory Disorders | 2 | 2019 | 1184 | 0.800 |
Why?
|
Apolipoproteins E | 4 | 2021 | 1438 | 0.760 |
Why?
|
Astrocytes | 5 | 2022 | 1270 | 0.710 |
Why?
|
Receptors, CXCR | 1 | 2019 | 52 | 0.690 |
Why?
|
Nerve Degeneration | 2 | 2020 | 748 | 0.640 |
Why?
|
Macrophage-1 Antigen | 1 | 2018 | 290 | 0.600 |
Why?
|
Nootropic Agents | 1 | 2018 | 160 | 0.580 |
Why?
|
Plaque, Amyloid | 5 | 2023 | 729 | 0.520 |
Why?
|
Brain | 18 | 2024 | 26385 | 0.500 |
Why?
|
Neurodegenerative Diseases | 2 | 2020 | 1061 | 0.500 |
Why?
|
Haplotypes | 1 | 2020 | 2779 | 0.450 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1889 | 0.410 |
Why?
|
Models, Statistical | 2 | 2023 | 5102 | 0.390 |
Why?
|
Neurofibrillary Tangles | 3 | 2023 | 439 | 0.390 |
Why?
|
Genomics | 4 | 2021 | 5720 | 0.380 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2245 | 0.370 |
Why?
|
Neurons | 5 | 2020 | 9338 | 0.360 |
Why?
|
Energy Metabolism | 1 | 2020 | 2899 | 0.340 |
Why?
|
Frontotemporal Dementia | 2 | 2024 | 248 | 0.340 |
Why?
|
Amyloid beta-Peptides | 7 | 2024 | 3587 | 0.340 |
Why?
|
Semantics | 2 | 2012 | 584 | 0.330 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3505 | 0.330 |
Why?
|
Calcineurin | 2 | 2019 | 226 | 0.310 |
Why?
|
Database Management Systems | 1 | 2008 | 270 | 0.300 |
Why?
|
Information Storage and Retrieval | 2 | 2012 | 824 | 0.290 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2017 | 143 | 0.270 |
Why?
|
Metformin | 2 | 2023 | 835 | 0.270 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2024 | 1414 | 0.270 |
Why?
|
Pick Disease of the Brain | 1 | 2024 | 43 | 0.230 |
Why?
|
Administration, Intravesical | 1 | 2023 | 91 | 0.230 |
Why?
|
Internet | 3 | 2012 | 3064 | 0.220 |
Why?
|
Cryoprotective Agents | 1 | 2024 | 112 | 0.220 |
Why?
|
Dimethyl Sulfoxide | 1 | 2024 | 249 | 0.220 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 9438 | 0.210 |
Why?
|
Receptors, GABA | 2 | 2022 | 288 | 0.200 |
Why?
|
Cyclohexylamines | 1 | 2020 | 21 | 0.190 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2020 | 88 | 0.190 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12261 | 0.180 |
Why?
|
Probability | 2 | 2023 | 2505 | 0.180 |
Why?
|
BCG Vaccine | 1 | 2023 | 369 | 0.180 |
Why?
|
Information Dissemination | 1 | 2008 | 1099 | 0.180 |
Why?
|
Phenylenediamines | 1 | 2020 | 90 | 0.180 |
Why?
|
Software | 2 | 2011 | 4443 | 0.180 |
Why?
|
Mice | 15 | 2024 | 81183 | 0.180 |
Why?
|
Alleles | 2 | 2021 | 6933 | 0.170 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2019 | 86 | 0.170 |
Why?
|
Apolipoprotein E4 | 1 | 2023 | 668 | 0.170 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3386 | 0.170 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2020 | 528 | 0.170 |
Why?
|
Carbolines | 1 | 2020 | 265 | 0.160 |
Why?
|
Lewy Body Disease | 1 | 2020 | 229 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17446 | 0.160 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 238 | 0.160 |
Why?
|
Mitochondrial Membranes | 1 | 2019 | 175 | 0.150 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2019 | 154 | 0.150 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 157 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 1000 | 0.150 |
Why?
|
Parkinson Disease | 1 | 2011 | 2775 | 0.150 |
Why?
|
Aging | 4 | 2021 | 8664 | 0.150 |
Why?
|
Humans | 42 | 2024 | 744343 | 0.150 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 464 | 0.150 |
Why?
|
Animals | 21 | 2024 | 168757 | 0.150 |
Why?
|
Neuroglia | 2 | 2019 | 927 | 0.150 |
Why?
|
Neuropeptides | 1 | 2023 | 942 | 0.150 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 25 | 0.140 |
Why?
|
RNA, Messenger | 4 | 2024 | 13033 | 0.140 |
Why?
|
Administration, Intranasal | 1 | 2018 | 446 | 0.140 |
Why?
|
Antimalarials | 1 | 2023 | 905 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.140 |
Why?
|
Cognition | 3 | 2023 | 6770 | 0.140 |
Why?
|
Muscular Dystrophies | 1 | 2018 | 393 | 0.140 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2018 | 282 | 0.140 |
Why?
|
Membrane Transport Proteins | 2 | 2019 | 1028 | 0.140 |
Why?
|
Genome, Fungal | 1 | 1997 | 204 | 0.130 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2023 | 859 | 0.130 |
Why?
|
Aged | 11 | 2023 | 163280 | 0.130 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18029 | 0.130 |
Why?
|
Homozygote | 1 | 2020 | 1785 | 0.130 |
Why?
|
Databases, Factual | 2 | 2008 | 7729 | 0.130 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 1338 | 0.120 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 726 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 721 | 0.120 |
Why?
|
Synapses | 2 | 2021 | 1728 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2022 | 1041 | 0.120 |
Why?
|
Proteomics | 3 | 2023 | 3638 | 0.120 |
Why?
|
Cerebrovascular Disorders | 1 | 2021 | 1504 | 0.120 |
Why?
|
Presenilin-1 | 1 | 2017 | 635 | 0.120 |
Why?
|
Random Allocation | 1 | 2018 | 2429 | 0.110 |
Why?
|
Mitochondria | 3 | 2024 | 3520 | 0.110 |
Why?
|
Cells, Cultured | 5 | 2024 | 19229 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 35421 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1117 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1017 | 0.110 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15540 | 0.110 |
Why?
|
tau Proteins | 2 | 2024 | 1868 | 0.110 |
Why?
|
Histones | 2 | 2013 | 2599 | 0.100 |
Why?
|
Memory, Short-Term | 1 | 2018 | 975 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2703 | 0.100 |
Why?
|
Delirium | 1 | 2023 | 1609 | 0.100 |
Why?
|
Inflammation | 3 | 2020 | 10638 | 0.100 |
Why?
|
Ubiquitins | 1 | 2013 | 384 | 0.100 |
Why?
|
Hematopoiesis | 1 | 2020 | 2072 | 0.100 |
Why?
|
Survival Analysis | 1 | 2023 | 10252 | 0.090 |
Why?
|
Mice, Transgenic | 6 | 2019 | 9734 | 0.090 |
Why?
|
Male | 16 | 2023 | 350118 | 0.090 |
Why?
|
Medical Informatics Applications | 1 | 2012 | 186 | 0.090 |
Why?
|
Memory | 1 | 2020 | 2174 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6622 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2023 | 5317 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2021 | 13989 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11725 | 0.080 |
Why?
|
Huntington Disease | 2 | 2013 | 1124 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12354 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2025 | 0.080 |
Why?
|
Cohort Studies | 2 | 2023 | 40561 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2859 | 0.080 |
Why?
|
Axons | 1 | 2016 | 1684 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1012 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3703 | 0.080 |
Why?
|
Cerebrovascular Circulation | 1 | 2018 | 2731 | 0.080 |
Why?
|
Proteins | 2 | 2000 | 6103 | 0.070 |
Why?
|
Calcium | 1 | 2020 | 5756 | 0.070 |
Why?
|
Oxidation-Reduction | 2 | 2024 | 2187 | 0.070 |
Why?
|
Female | 11 | 2023 | 380194 | 0.070 |
Why?
|
Cytokines | 2 | 2018 | 7322 | 0.070 |
Why?
|
Corpus Striatum | 1 | 2012 | 1221 | 0.070 |
Why?
|
Saccharomyces cerevisiae | 1 | 1997 | 2752 | 0.070 |
Why?
|
Electroencephalography | 1 | 2021 | 6150 | 0.070 |
Why?
|
Algorithms | 3 | 2023 | 13881 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2022 | 4468 | 0.070 |
Why?
|
Blood Pressure | 1 | 2021 | 8554 | 0.060 |
Why?
|
Genotype | 1 | 2020 | 12951 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16365 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 3002 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2011 | 1431 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3523 | 0.060 |
Why?
|
Biomedical Research | 2 | 2012 | 3309 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13284 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 21827 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19905 | 0.060 |
Why?
|
Ethyl Ethers | 1 | 2023 | 20 | 0.060 |
Why?
|
Caenorhabditis elegans | 3 | 2023 | 1419 | 0.060 |
Why?
|
Stathmin | 1 | 2024 | 71 | 0.060 |
Why?
|
Genome | 1 | 2012 | 1808 | 0.060 |
Why?
|
Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.060 |
Why?
|
Longevity | 2 | 2023 | 1070 | 0.060 |
Why?
|
Ethers | 1 | 2023 | 75 | 0.060 |
Why?
|
Chromogranin A | 1 | 2023 | 54 | 0.060 |
Why?
|
United States | 2 | 2022 | 69872 | 0.060 |
Why?
|
Solitary Nucleus | 1 | 2023 | 63 | 0.060 |
Why?
|
Genetic Loci | 1 | 2012 | 2575 | 0.050 |
Why?
|
Chromogranins | 1 | 2023 | 160 | 0.050 |
Why?
|
Computational Biology | 3 | 2021 | 3521 | 0.050 |
Why?
|
Entorhinal Cortex | 1 | 2023 | 272 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 4043 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2022 | 204 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2024 | 3086 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2022 | 229 | 0.050 |
Why?
|
Gliosis | 1 | 2021 | 245 | 0.050 |
Why?
|
Oleic Acid | 1 | 2020 | 85 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2023 | 690 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2020 | 14557 | 0.040 |
Why?
|
Apoptosis | 1 | 2016 | 9727 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2023 | 634 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2020 | 270 | 0.040 |
Why?
|
Models, Molecular | 2 | 2000 | 5456 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15519 | 0.040 |
Why?
|
Aldehydes | 1 | 2020 | 167 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23403 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 670 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 810 | 0.040 |
Why?
|
RNA Splicing | 1 | 2024 | 907 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2020 | 297 | 0.040 |
Why?
|
Presenilins | 1 | 2019 | 54 | 0.040 |
Why?
|
Hospitals, General | 1 | 2023 | 749 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 692 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2023 | 3479 | 0.040 |
Why?
|
Myotonic Dystrophy | 1 | 2018 | 78 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 734 | 0.040 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 294 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Methanococcus | 1 | 1997 | 10 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3679 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 976 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11366 | 0.040 |
Why?
|
Medical Records | 1 | 2022 | 1413 | 0.040 |
Why?
|
Glycolysis | 1 | 2021 | 827 | 0.040 |
Why?
|
Permeability | 1 | 2019 | 738 | 0.040 |
Why?
|
Cytosol | 1 | 2020 | 901 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1654 | 0.040 |
Why?
|
Independent Living | 1 | 2021 | 568 | 0.040 |
Why?
|
HIV Infections | 1 | 2023 | 16718 | 0.040 |
Why?
|
Serotonin | 1 | 2021 | 1017 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2019 | 302 | 0.040 |
Why?
|
NFATC Transcription Factors | 1 | 2018 | 381 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.030 |
Why?
|
Suppression, Genetic | 1 | 2016 | 196 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2021 | 838 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2016 | 128 | 0.030 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2018 | 256 | 0.030 |
Why?
|
Antioxidants | 1 | 2024 | 1663 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7799 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1020 | 0.030 |
Why?
|
Middle Aged | 6 | 2023 | 213383 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 871 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2000 | 2256 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14722 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 2234 | 0.030 |
Why?
|
Cell Survival | 1 | 2024 | 5882 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2203 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 597 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3920 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2183 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3341 | 0.030 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2019 | 1121 | 0.030 |
Why?
|
Open Reading Frames | 1 | 1997 | 810 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13815 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1486 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15076 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1997 | 912 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3846 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1581 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2019 | 852 | 0.030 |
Why?
|
Blotting, Western | 1 | 2020 | 5179 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2019 | 1026 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2018 | 1783 | 0.030 |
Why?
|
Necrosis | 1 | 2016 | 1643 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 12072 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1300 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2022 | 2872 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2023 | 5097 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 893 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8436 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
Acetylation | 1 | 2012 | 1085 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77449 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2018 | 3420 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2585 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3589 | 0.020 |
Why?
|
Spinal Cord | 1 | 2016 | 1809 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6196 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 789 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4286 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1997 | 2716 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9648 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1538 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3675 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 8949 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 72290 | 0.020 |
Why?
|
MicroRNAs | 1 | 2021 | 3752 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2012 | 1783 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3462 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16689 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6234 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3494 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15295 | 0.010 |
Why?
|
Retinoid X Receptors | 1 | 2000 | 93 | 0.010 |
Why?
|
Receptors, Retinoic Acid | 1 | 2000 | 232 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7722 | 0.010 |
Why?
|
Dimerization | 1 | 2000 | 893 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2000 | 936 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 18111 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63114 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 29786 | 0.010 |
Why?
|
Binding Sites | 1 | 2000 | 6114 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2000 | 3023 | 0.010 |
Why?
|
Adult | 1 | 2021 | 214055 | 0.000 |
Why?
|
Transcription Factors | 1 | 2000 | 12208 | 0.000 |
Why?
|